Alnylam Pharmaceuticals Inc at Cowen Health Care Conference Transcript
Good morning, everyone, and welcome to the 2019 Cowen Healthcare Conference. I'm Irina Margine. I'm on the Biotech Equity Research team.
And it is my pleasure to introduce this morning, Barry Greene, who is President and COO of Alnylam.
Thanks, Irina. I appreciate being here, and I appreciate the organizers for having us. I apologize for the technical difficulties. I'm Barry Greene, President of Alnylam, and it's my pleasure to provide an update on the extraordinary progress we're making in developing an entirely new class of medicines. That's RNAi therapeutics.
As many of you know, when we started the company 16 years ago, we believe that this natural biologic process in all of our cells that regulates genes could be harnessed to create a new class of medicines by down-regulating disease-causing genes. We've demonstrated over the years passing all the technical hurdles, like delivery. And we were really
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
